These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 33550421)

  • 21. Vaccination with Replication Deficient Adenovectors Encoding YF-17D Antigens Induces Long-Lasting Protection from Severe Yellow Fever Virus Infection in Mice.
    Bassi MR; Larsen MA; Kongsgaard M; Rasmussen M; Buus S; Stryhn A; Thomsen AR; Christensen JP
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004464. PubMed ID: 26886513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Active assessment of adverse events following yellow fever vaccination of persons aged 60 years and more.
    Miyaji KT; Luiz AM; Lara AN; do Socorro Souza Chaves T; Piorelli Rde O; Lopes MH; Sartori AM
    Hum Vaccin Immunother; 2013 Feb; 9(2):277-82. PubMed ID: 23291944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seroconversion and antibody persistence after yellow fever vaccination in people living with HIV: impact of baseline HIV viral load and yellow fever seropositivity.
    Martin C; Florence E; Domingo C; Delforge M; De Wit S; Dauby N
    J Travel Med; 2022 Dec; 29(8):. PubMed ID: 35285913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Yellow fever vaccination coverage among children in Brazilian capitals.
    Veras MA; Flannery B; de Moraes JC; da Silva Teixeira AM; Luna EJ;
    Vaccine; 2010 Sep; 28(39):6478-82. PubMed ID: 20674878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydroxyurea (hydroxycarbamide) genotoxicity in pediatric patients with sickle cell disease.
    Rodriguez A; Duez P; Dedeken L; Cotton F; Ferster A
    Pediatr Blood Cancer; 2018 Jul; 65(7):e27022. PubMed ID: 29512872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody responses to yellow fever vaccine in 9 to 11-month-old Malian and Ghanaian children.
    Idoko OT; Mohammed N; Ansah P; Hodgson A; Tapia MD; Sow SO; Chowdhury PR; Niedrig M; Saathoff E; Kampmann B
    Expert Rev Vaccines; 2019 Aug; 18(8):867-875. PubMed ID: 31269829
    [No Abstract]   [Full Text] [Related]  

  • 27. Validation of a yellow fever vaccine model using data from primary vaccination in children and adults, re-vaccination and dose-response in adults and studies with immunocompromised individuals.
    Bonin CRB; Fernandes GC; de Menezes Martins R; Camacho LAB; Teixeira-Carvalho A; da Mota LMH; de Lima SMB; Campi-Azevedo AC; Martins-Filho OA; Dos Santos RW; Lobosco M;
    BMC Bioinformatics; 2020 Dec; 21(Suppl 17):551. PubMed ID: 33308151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Yellow fever vaccine: an effective vaccine for travelers.
    Verma R; Khanna P; Chawla S
    Hum Vaccin Immunother; 2014; 10(1):126-8. PubMed ID: 24056028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Yellow fever in children and adolescents previously immunized in Minas Gerais State, Brazil.
    Diniz LMO; Romanelli RMC; Bentes AA; Silva NLCD; Soares Cruzeiro FR; Marcial TM; Ribeiro JGL
    Vaccine; 2020 Oct; 38(44):6954-6958. PubMed ID: 32950299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity and Protection After Vaccination With a Modified Vaccinia Virus Ankara-Vectored Yellow Fever Vaccine in the Hamster Model.
    Julander JG; Testori M; Cheminay C; Volkmann A
    Front Immunol; 2018; 9():1756. PubMed ID: 30116244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eliminating yellow fever epidemics in Africa: Vaccine demand forecast and impact modelling.
    Jean K; Hamlet A; Benzler J; Cibrelus L; Gaythorpe KAM; Sall A; Ferguson NM; Garske T
    PLoS Negl Trop Dis; 2020 May; 14(5):e0008304. PubMed ID: 32379756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CHRONOVAC VOYAGEUR: A study of the immune response to yellow fever vaccine among infants previously immunized against measles.
    Goujon C; Gougeon ML; Tondeur L; Poirier B; Seffer V; Desprès P; Consigny PH; Vray M;
    Vaccine; 2017 Oct; 35(45):6166-6171. PubMed ID: 28958813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Yellow fever (YF) vaccination does not increase dengue severity: A retrospective study based on 11,448 dengue notifications in a YF and dengue endemic region.
    Luppe MJ; Verro AT; Barbosa AS; Nogueira ML; Undurraga EA; da Silva NS
    Travel Med Infect Dis; 2019; 30():25-31. PubMed ID: 31075425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unpredictable checks of yellow fever vaccination certificates upon arrival in Tanzania.
    Schönenberger S; Hatz C; Bühler S
    J Travel Med; 2016 May; 23(5):. PubMed ID: 27296582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Previous biological therapy and impairment of the IFN-γ/IL-10 axis are associated with low immune response to 17DD-YF vaccination in patients with spondyloarthritis.
    Casagrande TZ; Costa-Rocha IAD; Gavi MBRO; Miyamoto ST; Martins PC; Serrano ÉV; Dinis VG; Machado KLLL; Gouvea SA; Caser LC; Campi-Azevedo AC; Teixeira-Carvalho A; Peruhype-Magalhães V; Bissoli MF; Gouvea MDPG; Lima SMB; Miranda EH; Trindade GF; Lyra DGP; Burian APN; Neto LFDSP; da Mota LMH; Martins-Filho OA; Valim V
    Vaccine; 2022 Jul; 40(32):4580-4593. PubMed ID: 35728990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences between coverage of yellow fever vaccine and the first dose of measles-containing vaccine: A desk review of global data sources.
    Adrien N; Hyde TB; Gacic-Dobo M; Hombach J; Krishnaswamy A; Lambach P
    Vaccine; 2019 Jul; 37(32):4511-4517. PubMed ID: 31266670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is the absence or intermittent YF vaccination the major contributor to its persistent outbreaks in eastern Africa?
    Baba MM; Ikusemoran M
    Biochem Biophys Res Commun; 2017 Oct; 492(4):548-557. PubMed ID: 28109882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of two yellow fever vaccines for routine immunization programs in Argentina.
    Ripoll C; Ponce A; Wilson MM; Sharif N; Vides JB; Armoni J; Teuwen DE
    Hum Vaccin; 2008; 4(2):121-6. PubMed ID: 18382132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 17D yellow fever vaccines: new insights. A report of a workshop held during the World Congress on medicine and health in the tropics, Marseille, France, Monday 12 September 2005.
    Barrett AD; Monath TP; Barban V; Niedrig M; Teuwen DE
    Vaccine; 2007 Apr; 25(15):2758-65. PubMed ID: 17368349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Higher oxygen saturation with hydroxyurea in paediatric sickle cell disease.
    van Geyzel L; Arigliani M; Inusa B; Singh B; Kozlowska W; Chakravorty S; Bossley CJ; Ruiz G; Rees D; Gupta A
    Arch Dis Child; 2020 Jun; 105(6):575-579. PubMed ID: 31871045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.